1 / 5

Point of Care (PoC) Diagnostics Market Share, Growth Forecast- Global Industry Outlook

Point of Care (PoC) Diagnostics Market<br>

swati15
Télécharger la présentation

Point of Care (PoC) Diagnostics Market Share, Growth Forecast- Global Industry Outlook

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Point of Care (PoC) Diagnostics Market To Reach USD 50.51 Billion By 2026 www.reportsanddata.com

  2. Market Summary According to the current analysis of Reports and Data, the global Point of Care (PoC) Diagnostics market was valued at USD 23.98 Billion in 2018 and is expected to reach USD 50.51 Billion by year 2026, at a CAGR of 9.6%. According to the Centers for Disease Control and Prevention (CDC), in US alone currently more than 100 million adults are living with diabetes or pre-diabetes. Cardiovascular diseases (CVD) account for approximately 800,000 deaths in the US. On average, one person dies from CVD every 40 seconds in the US. CVD also causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union. Point-of-care (POC) diagnostics or near-patient testing is a medical diagnostic test that allows physicians and medical staff to correctly attain real-time, lab-quality diagnostic results within minutes rather than hours. Through the use of portable blood analysers, testing at the “point of care” streamlines the diagnostic process and helps ensure patients receive the most effective and efficient care when and where it is needed. www.reportsanddata.com Read More: https://www.reportsanddata.com/report-detail/point-of-care-poc-diagnostics- market

  3. Market Summary Further key findings from the report suggest: Point of Care (PoC) Diagnostics market is fastest growing at a CAGR of 3% in Asia Pacific due to rising prevalence of strategic initiatives taken by international players to improve healthcare infrastructure and increasing awareness in developing countries like China and India The market for Molecular diagnostics segment is projected to have the highest CAGR during the forecasted period because of the growing advancements in technology, increasing initiatives of market players for developing POC molecular diagnostics products, and resource-limited settings Europe is the second largest region with a share of 33.1 % due to the increased adoption of advanced point of care diagnostic devices, rise in awareness about innovative and advanced applications of point of care diagnostic devices, and rapidly aging population coupled with increase in incidences of diabetes and liver diseases The prescription-based testing segment holds the largest share of the global point-of-care diagnostics market in 2018 owing to the increasing incidence and prevalence of lifestyle diseases and the lack of awareness on OTC devices in developing nations • • • www.reportsanddata.com • Key participants include Abbott, F. Hoffmann-La Roche and Siemens Healthineers. •

  4. Market Summary For the purpose of the study, this Reports and Data has segmented the Global Point of Care (PoC) Diagnostics Market on the basis of product type, platform type, prescription mode, end user and the regional outlook: Product Type (Revenue, USD Million; 2016–2026) • Coagulation Testing Products • PT/INR Testing Products • Activated Clotting Time (ACT/APTT) Testing Products • Pregnancy and Fertility Testing Products Platform Type (Revenue, USD Million; 2016–2026) • Agglutination assays • Biosensors • Dipsticks • Lateral Flow Assays • Microfluidics • Molecular Diagnostics • Solid phase www.reportsanddata.com

  5. About Us About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. Contact US Contact US We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. www.reportsanddata.com John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

More Related